- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Automated Breast Ultrasound Far Faster than Hand-held
Researchers found ABUS takes three minutes of physician interpretation time compared with 20 to 30 minutes for hand-held ultrasounds.
Automated breast ultrasounds take an average of only three minutes of physician time compared with 20 to 30 minutes that it takes for hand-held ultrasounds, say researchers from George Washington University Medical School in Washington, DC. The results of their study were presented at the American Roentgen Ray Society in Vancouver, Canada.
Dense breasts are difficult to image by mammography, causing one-third of cancers to be missed, thus requiring ultrasounds for further examination, researchers said.
“Ultrasound can and does detect additional, clinically significant, invasive, node negative breast cancers, hat are not seen on mammography,” said Rachel Brem, MD, the study’s lead author. Because traditional ultrasound screening is time consuming, a quicker three-minute technique is a “game changer,” she added.
To evaluate the automated breast ultrasound effectiveness, the researchers assessed how long it took for radiologists to interpret the automated exam. The mean reading time for the three radiologists in the study was 173.4 seconds.
An FDA panel recently voted in favor of the automated breast ultrasound efficacy and safety, although its use remains limited now.
MRI or Ultrasound for Evaluating Pelvic Endometriosis?: Seven Takeaways from a New Literature Review
September 13th 2024While noting the strength of MRI for complete staging of disease and ultrasound’s ability to provide local disease characterization, the authors of a new literature review suggest the two modalities offer comparable results for diagnosing pelvic endometriosis.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Controlled Contrast Delivery Method for Ultrasound Imaging of Fallopian Tubes
September 9th 2024Facilitating natural contrast delivery through an intrauterine catheter, FemChec can be utilized for ultrasound assessment of fallopian tubes and may provide diagnostic confirmation for an emerging non-surgical option for permanent birth control.
FDA Clears Emerging Cardiovascular Point-of-Care Ultrasound Platform
August 22nd 2024Combining four CAD modules for valvular pathologies with a variety of automated measurements, the AI-enabled AISAP Cardio ultrasound system reportedly facilitates up to a 90 percent accuracy rate in detecting common cardiac conditions.
Predicting DCIS Upgrade to Invasive Breast Cancer: Can Contrast-Enhanced Ultrasound Have an Impact?
August 21st 2024Adding two key findings from contrast-enhanced ultrasound to a predictive model of mammography, conventional ultrasound and clinicopathological findings led to a 86.1 percent AUROC for predicting the upgrading of ductal carcinoma in situ to invasive breast cancer, according to new research.
